Core Insights - Altria Group, Inc. (MO) reached a new 52-week high of $67.87, driven by strong earnings, growth in oral tobacco, and shareholder returns, prompting investor considerations on stock positions [1][8][10] Stock Performance - Over the past month, Altria's stock surged 14.9%, outperforming the Zacks Tobacco industry's growth of 1.4%, the Consumer Staples sector's 0.6%, and the S&P 500 index's 1.9% [2] - Technical indicators show Altria's stock trading at $67.58, above its 50-day and 200-day moving averages of $60.68 and $55.78, indicating strong upward momentum [6][7] Earnings and Revenue - In Q2 2025, Altria's adjusted EPS grew 8.3% year-over-year to $1.44, supported by pricing, efficiencies, and share repurchases, with revenues net of excise taxes steady at $5.29 billion [11][12] - Management raised the lower end of its 2025 adjusted EPS guidance to $5.35-$5.45, reflecting a growth rate of 3.0% to 5.0% [11] Segment Performance - The oral tobacco segment, particularly the on! nicotine pouch brand, saw a 26.5% shipment growth, contributing to a 10.9% increase in adjusted operating income and margin expansion of 310 basis points to 68.7% [12] - The smokeable products segment demonstrated resilience with a 4.2% rise in adjusted operating income and margin expansion of 290 basis points to 64.5%, with Marlboro's market share increasing to 59.5% [13] Market Challenges - Altria faces significant volume pressure in its core combustible segment, with domestic cigarette shipments declining by 10.2% in Q2 2025 due to industry decline and competition from flavored disposable e-vapor products [14] Valuation - Altria's forward 12-month P/E ratio is 12.31, below the one-year median of 10.52 and the industry average of 15.42, positioning it as a compelling value opportunity compared to peers [15] Earnings Estimates - The Zacks Consensus Estimate for Altria's earnings for the current and next fiscal year has risen to $5.39 and $5.55 per share, indicating year-over-year growth rates of 5.3% and 2.9% respectively [17]
Should You Buy Altria Stock as it Hits a New 52-Week High?